Now, last week I introduced the BENEFIT Act. It is legislation to ensure that patient experience and patient-focused drug development data can be considered as part of FDA's benefit/risk framework for drug approval.
DeGette introduced legislation to prioritize patient experience in FDA drug approval processes.
Share
More from Diana DeGette
I would suggest, Madam Chair, that we actually have hearings directed at specific programs.
I was dismayed to hear that you did not receive the funding that you need to do your job. And I was pleased to hear that at least some of that funding is included in President Biden's budget this year.
We need a strong, bold, hardened leader who will hold Trump accountable, and when we win the majority in November, will have real power to move the U.S. to a more just and affordable America … That leader is me.
I understand that most of our Republican House colleagues voted against these landmark laws.
Other voices in this conversation
